Nicholas F Evageliou

7PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersInfant and child healthSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 17, 2026
Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies.

|May 18, 2026
Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.

|Sep 19, 2025
AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy.

Alix E Seif, Sara L McDonough, Emily M Becker-Haimes

|Jun 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.

Daniel J Benedetti, Nicholas G Cost, Peter F Ehrlich

|Jan 29, 2025
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.

Daniela Perotti, Maureen J O'Sullivan, Amy L Walz

|Oct 30, 2023
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.

Nicholas Evageliou, Lindsay A Renfro, James Geller

Pageof 2

Frequent Collaborators

3 joint publications

Andrew L Hong

3 joint publications

Daniel J Benedetti

3 joint publications

Elizabeth A Mullen

2 joint publications

James I Geller